Tilia Fiduciary Partners Inc. Cuts Stock Holdings in UnitedHealth Group Incorporated $UNH

Tilia Fiduciary Partners Inc. lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.8% during the second quarter, HoldingsChannel.com reports. The firm owned 3,723 shares of the healthcare conglomerate’s stock after selling 230 shares during the period. Tilia Fiduciary Partners Inc.’s holdings in UnitedHealth Group were worth $1,161,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in UNH. Nuveen LLC purchased a new position in shares of UnitedHealth Group in the 1st quarter valued at $3,846,764,000. Vanguard Group Inc. raised its stake in shares of UnitedHealth Group by 6.6% in the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock valued at $47,519,620,000 after acquiring an additional 5,583,343 shares during the period. Wellington Management Group LLP increased its stake in UnitedHealth Group by 10.6% during the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock worth $13,537,859,000 after buying an additional 2,486,839 shares during the period. National Bank of Canada FI increased its stake in UnitedHealth Group by 137.8% during the 1st quarter. National Bank of Canada FI now owns 1,641,177 shares of the healthcare conglomerate’s stock worth $859,518,000 after buying an additional 950,928 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its stake in UnitedHealth Group by 13.6% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate’s stock worth $3,702,736,000 after buying an additional 847,054 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently issued reports on UNH shares. Oppenheimer dropped their price target on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 30th. Royal Bank Of Canada decreased their price objective on shares of UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating for the company in a report on Wednesday, July 30th. Piper Sandler decreased their price objective on shares of UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating for the company in a report on Wednesday, July 30th. Baird R W lowered shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a report on Thursday, July 31st. Finally, Robert W. Baird reissued an “underperform” rating and set a $198.00 price objective (down from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Sixteen analysts have rated the stock with a Buy rating, six have given a Hold rating and four have assigned a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $358.95.

UnitedHealth Group Trading Up 1.8%

NYSE UNH opened at $360.17 on Friday. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73. The company has a 50-day simple moving average of $307.84 and a 200-day simple moving average of $355.58. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The firm has a market capitalization of $326.20 billion, a PE ratio of 15.61, a price-to-earnings-growth ratio of 2.30 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same period last year, the firm posted $6.80 earnings per share. The company’s quarterly revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were given a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.5%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.